- Home
- GERN vs REX Comparison
GERN vs REX Comparison
Compare GERN & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GERN | REX |
|---|---|---|
| Founded | 1990 | 1980 |
| Country | United States | United States |
| Employees | 229 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | GERN | REX |
|---|---|---|
| Price | $1.46 | $35.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $2.17 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 16.5M | 141.9K |
| Earning Date | 01-01-0001 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.18 |
| Revenue | N/A | ★ $642,491,000.00 |
| Revenue This Year | $32.27 | $3.27 |
| Revenue Next Year | $60.16 | $17.11 |
| P/E Ratio | ★ N/A | $30.46 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.04 | $30.02 |
| 52 Week High | $2.01 | $64.95 |
Technical Indicators
Market Signals| Indicator | GERN | REX |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 62.24 |
| Support Level | $1.20 | $30.71 |
| Resistance Level | $1.68 | $43.62 |
| Average True Range (ATR) | 0.16 | 1.19 |
| MACD | -0.04 | 0.18 |
| Stochastic Oscillator | 5.08 | 87.26 |
Price Performance
Historical ComparisonAbout GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About REX REX American Resources Corporation
REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.